168 related articles for article (PubMed ID: 28117030)
21. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
22. Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429.
Guo Q; Lu L; Liao Y; Wang X; Zhang Y; Liu Y; Huang S; Sun H; Li Z; Zhao L
Cell Death Dis; 2018 Jan; 8(1):e3178. PubMed ID: 29324735
[TBL] [Abstract][Full Text] [Related]
23. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: does timing matter?
Modesitt SC; Parsons SJ
Gynecol Oncol; 2010 Nov; 119(2):351-7. PubMed ID: 20673975
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the p38 MAPK signaling pathway in S-phase cell-cycle arrest induced by Furazolidone in human hepatoma G2 cells.
Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
J Appl Toxicol; 2013 Dec; 33(12):1500-5. PubMed ID: 23112108
[TBL] [Abstract][Full Text] [Related]
26. ERRATUM.
Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
Oncol Res; 2016 Jan; 23(1):87. PubMed ID: 29021025
[TBL] [Abstract][Full Text] [Related]
27. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.
Zhu Y; Jiang Y; Shi L; Du L; Xu X; Wang E; Sun Y; Guo X; Zou B; Wang H; Wang C; Sun L; Zhen Y
Biomed Pharmacother; 2017 Mar; 87():527-538. PubMed ID: 28076833
[TBL] [Abstract][Full Text] [Related]
28. Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest.
Zhang Z; Leonard SS; Huang C; Vallyathan V; Castranova V; Shi X
Free Radic Biol Med; 2003 May; 34(10):1333-42. PubMed ID: 12726921
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Hu L; Hofmann J; Lu Y; Mills GB; Jaffe RB
Cancer Res; 2002 Feb; 62(4):1087-92. PubMed ID: 11861387
[TBL] [Abstract][Full Text] [Related]
30. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
[TBL] [Abstract][Full Text] [Related]
31. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
[TBL] [Abstract][Full Text] [Related]
32. Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway.
Ma YC; Su N; Shi XJ; Zhao W; Ke Y; Zi X; Zhao NM; Qin YH; Zhao HW; Liu HM
Toxicol Appl Pharmacol; 2015 Jan; 282(2):227-36. PubMed ID: 25450480
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
[TBL] [Abstract][Full Text] [Related]
34. Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience.
Watari H; Hosaka M; Mitamura T; Moriwaki M; Ohba Y; Todo Y; Takeda M; Ebina Y; Sakuragi N
Eur J Gynaecol Oncol; 2008; 29(6):573-7. PubMed ID: 19115681
[TBL] [Abstract][Full Text] [Related]
35. The G
Cui J; Wang J; Huang S; Jiang X; Li Y; Wu W; Zhang X
Food Chem Toxicol; 2018 May; 115():205-211. PubMed ID: 29545144
[TBL] [Abstract][Full Text] [Related]
36. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.
Chao JI; Su WC; Liu HF
Mol Cancer Ther; 2007 Nov; 6(11):3039-48. PubMed ID: 18025287
[TBL] [Abstract][Full Text] [Related]
37. p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposide.
Kurosu T; Takahashi Y; Fukuda T; Koyama T; Miki T; Miura O
Apoptosis; 2005 Oct; 10(5):1111-20. PubMed ID: 16151644
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.
Han X; Chen H; Zhou J; Steed H; Postovit LM; Fu Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30049957
[TBL] [Abstract][Full Text] [Related]
39. Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells.
Chen CH; Lin JY; Liu FH; Chang JL; Huang HM
Ann Hematol; 2008 Mar; 87(3):175-82. PubMed ID: 17929017
[TBL] [Abstract][Full Text] [Related]
40. Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis.
Mo Q; Zhang Y; Jin X; Gao Y; Wu Y; Hao X; Gao Q; Chen P
Tumour Biol; 2016 Nov; 37(11):14745-14755. PubMed ID: 27629142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
